AorTech licenses Elast-Eon to CHF (congestive heart failure) company
This article was originally published in Clinica
Executive Summary
Australian early-stage company Sunshine Heart is to use AorTech's Elast-Eon material to develop components for its device for treating congestive heart failure (CHF). The two companies have just signed an R&D and option agreement for the licensing and supply of Elast-Eon.